0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Legionnaire Disease Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18V1167
Home | Market Reports | Health| Health Conditions
Global Legionnaire Disease Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Legionnaire Disease Testing Market Research Report 2025

Code: QYRE-Auto-18V1167
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Legionnaire Disease Testing Market

The global market for Legionnaire Disease Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Legionnaires disease is atypical pneumonia caused by legionella bacteria.
North American market for Legionnaire Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Legionnaire Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Legionnaire Disease Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Legionnaire Disease Testing include Danaher, Bio-Rad, Abbott, Roche, Thermo Fischer Scientific, BD, Aquacert, BioMérieux, Idexx, Albagaia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Legionnaire Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Legionnaire Disease Testing.
The Legionnaire Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Legionnaire Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Legionnaire Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Legionnaire Disease Testing Market Report

Report Metric Details
Report Name Legionnaire Disease Testing Market
Segment by Type
  • Urinary Antigen Testing
  • Direct Fluorescent Antibody (DFA) Stain
  • Combination Testing (Culture and Urinary Antigen Testing)
  • Others
Segment by Application
  • Hospitals
  • Diagnostic Laboratories
  • Research Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danaher, Bio-Rad, Abbott, Roche, Thermo Fischer Scientific, BD, Aquacert, BioMérieux, Idexx, Albagaia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Legionnaire Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Legionnaire Disease Testing Market report?

Ans: The main players in the Legionnaire Disease Testing Market are Danaher, Bio-Rad, Abbott, Roche, Thermo Fischer Scientific, BD, Aquacert, BioMérieux, Idexx, Albagaia

What are the Application segmentation covered in the Legionnaire Disease Testing Market report?

Ans: The Applications covered in the Legionnaire Disease Testing Market report are Hospitals, Diagnostic Laboratories, Research Centers, Others

What are the Type segmentation covered in the Legionnaire Disease Testing Market report?

Ans: The Types covered in the Legionnaire Disease Testing Market report are Urinary Antigen Testing, Direct Fluorescent Antibody (DFA) Stain, Combination Testing (Culture and Urinary Antigen Testing), Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Legionnaire Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Urinary Antigen Testing
1.2.3 Direct Fluorescent Antibody (DFA) Stain
1.2.4 Combination Testing (Culture and Urinary Antigen Testing)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Legionnaire Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Legionnaire Disease Testing Market Perspective (2020-2031)
2.2 Global Legionnaire Disease Testing Growth Trends by Region
2.2.1 Global Legionnaire Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Legionnaire Disease Testing Historic Market Size by Region (2020-2025)
2.2.3 Legionnaire Disease Testing Forecasted Market Size by Region (2026-2031)
2.3 Legionnaire Disease Testing Market Dynamics
2.3.1 Legionnaire Disease Testing Industry Trends
2.3.2 Legionnaire Disease Testing Market Drivers
2.3.3 Legionnaire Disease Testing Market Challenges
2.3.4 Legionnaire Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Legionnaire Disease Testing Players by Revenue
3.1.1 Global Top Legionnaire Disease Testing Players by Revenue (2020-2025)
3.1.2 Global Legionnaire Disease Testing Revenue Market Share by Players (2020-2025)
3.2 Global Legionnaire Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Legionnaire Disease Testing Revenue
3.4 Global Legionnaire Disease Testing Market Concentration Ratio
3.4.1 Global Legionnaire Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Legionnaire Disease Testing Revenue in 2024
3.5 Global Key Players of Legionnaire Disease Testing Head office and Area Served
3.6 Global Key Players of Legionnaire Disease Testing, Product and Application
3.7 Global Key Players of Legionnaire Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Legionnaire Disease Testing Breakdown Data by Type
4.1 Global Legionnaire Disease Testing Historic Market Size by Type (2020-2025)
4.2 Global Legionnaire Disease Testing Forecasted Market Size by Type (2026-2031)
5 Legionnaire Disease Testing Breakdown Data by Application
5.1 Global Legionnaire Disease Testing Historic Market Size by Application (2020-2025)
5.2 Global Legionnaire Disease Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Legionnaire Disease Testing Market Size (2020-2031)
6.2 North America Legionnaire Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Legionnaire Disease Testing Market Size by Country (2020-2025)
6.4 North America Legionnaire Disease Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Legionnaire Disease Testing Market Size (2020-2031)
7.2 Europe Legionnaire Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Legionnaire Disease Testing Market Size by Country (2020-2025)
7.4 Europe Legionnaire Disease Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Legionnaire Disease Testing Market Size (2020-2031)
8.2 Asia-Pacific Legionnaire Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Legionnaire Disease Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Legionnaire Disease Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Legionnaire Disease Testing Market Size (2020-2031)
9.2 Latin America Legionnaire Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Legionnaire Disease Testing Market Size by Country (2020-2025)
9.4 Latin America Legionnaire Disease Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Legionnaire Disease Testing Market Size (2020-2031)
10.2 Middle East & Africa Legionnaire Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Legionnaire Disease Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Legionnaire Disease Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Legionnaire Disease Testing Introduction
11.1.4 Danaher Revenue in Legionnaire Disease Testing Business (2020-2025)
11.1.5 Danaher Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Legionnaire Disease Testing Introduction
11.2.4 Bio-Rad Revenue in Legionnaire Disease Testing Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Legionnaire Disease Testing Introduction
11.3.4 Abbott Revenue in Legionnaire Disease Testing Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Legionnaire Disease Testing Introduction
11.4.4 Roche Revenue in Legionnaire Disease Testing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Thermo Fischer Scientific
11.5.1 Thermo Fischer Scientific Company Details
11.5.2 Thermo Fischer Scientific Business Overview
11.5.3 Thermo Fischer Scientific Legionnaire Disease Testing Introduction
11.5.4 Thermo Fischer Scientific Revenue in Legionnaire Disease Testing Business (2020-2025)
11.5.5 Thermo Fischer Scientific Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Legionnaire Disease Testing Introduction
11.6.4 BD Revenue in Legionnaire Disease Testing Business (2020-2025)
11.6.5 BD Recent Development
11.7 Aquacert
11.7.1 Aquacert Company Details
11.7.2 Aquacert Business Overview
11.7.3 Aquacert Legionnaire Disease Testing Introduction
11.7.4 Aquacert Revenue in Legionnaire Disease Testing Business (2020-2025)
11.7.5 Aquacert Recent Development
11.8 BioMérieux
11.8.1 BioMérieux Company Details
11.8.2 BioMérieux Business Overview
11.8.3 BioMérieux Legionnaire Disease Testing Introduction
11.8.4 BioMérieux Revenue in Legionnaire Disease Testing Business (2020-2025)
11.8.5 BioMérieux Recent Development
11.9 Idexx
11.9.1 Idexx Company Details
11.9.2 Idexx Business Overview
11.9.3 Idexx Legionnaire Disease Testing Introduction
11.9.4 Idexx Revenue in Legionnaire Disease Testing Business (2020-2025)
11.9.5 Idexx Recent Development
11.10 Albagaia
11.10.1 Albagaia Company Details
11.10.2 Albagaia Business Overview
11.10.3 Albagaia Legionnaire Disease Testing Introduction
11.10.4 Albagaia Revenue in Legionnaire Disease Testing Business (2020-2025)
11.10.5 Albagaia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Legionnaire Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Urinary Antigen Testing
 Table 3. Key Players of Direct Fluorescent Antibody (DFA) Stain
 Table 4. Key Players of Combination Testing (Culture and Urinary Antigen Testing)
 Table 5. Key Players of Others
 Table 6. Global Legionnaire Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Legionnaire Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Legionnaire Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Legionnaire Disease Testing Market Share by Region (2020-2025)
 Table 10. Global Legionnaire Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Legionnaire Disease Testing Market Share by Region (2026-2031)
 Table 12. Legionnaire Disease Testing Market Trends
 Table 13. Legionnaire Disease Testing Market Drivers
 Table 14. Legionnaire Disease Testing Market Challenges
 Table 15. Legionnaire Disease Testing Market Restraints
 Table 16. Global Legionnaire Disease Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Legionnaire Disease Testing Market Share by Players (2020-2025)
 Table 18. Global Top Legionnaire Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Legionnaire Disease Testing as of 2024)
 Table 19. Ranking of Global Top Legionnaire Disease Testing Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Legionnaire Disease Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Legionnaire Disease Testing, Headquarters and Area Served
 Table 22. Global Key Players of Legionnaire Disease Testing, Product and Application
 Table 23. Global Key Players of Legionnaire Disease Testing, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Legionnaire Disease Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Legionnaire Disease Testing Revenue Market Share by Type (2020-2025)
 Table 27. Global Legionnaire Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Legionnaire Disease Testing Revenue Market Share by Type (2026-2031)
 Table 29. Global Legionnaire Disease Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Legionnaire Disease Testing Revenue Market Share by Application (2020-2025)
 Table 31. Global Legionnaire Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Legionnaire Disease Testing Revenue Market Share by Application (2026-2031)
 Table 33. North America Legionnaire Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Legionnaire Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Legionnaire Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Legionnaire Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Legionnaire Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Legionnaire Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Legionnaire Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Legionnaire Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Legionnaire Disease Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Legionnaire Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Legionnaire Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Legionnaire Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Legionnaire Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Legionnaire Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Legionnaire Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Danaher Company Details
 Table 49. Danaher Business Overview
 Table 50. Danaher Legionnaire Disease Testing Product
 Table 51. Danaher Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 52. Danaher Recent Development
 Table 53. Bio-Rad Company Details
 Table 54. Bio-Rad Business Overview
 Table 55. Bio-Rad Legionnaire Disease Testing Product
 Table 56. Bio-Rad Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Recent Development
 Table 58. Abbott Company Details
 Table 59. Abbott Business Overview
 Table 60. Abbott Legionnaire Disease Testing Product
 Table 61. Abbott Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 62. Abbott Recent Development
 Table 63. Roche Company Details
 Table 64. Roche Business Overview
 Table 65. Roche Legionnaire Disease Testing Product
 Table 66. Roche Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 67. Roche Recent Development
 Table 68. Thermo Fischer Scientific Company Details
 Table 69. Thermo Fischer Scientific Business Overview
 Table 70. Thermo Fischer Scientific Legionnaire Disease Testing Product
 Table 71. Thermo Fischer Scientific Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 72. Thermo Fischer Scientific Recent Development
 Table 73. BD Company Details
 Table 74. BD Business Overview
 Table 75. BD Legionnaire Disease Testing Product
 Table 76. BD Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 77. BD Recent Development
 Table 78. Aquacert Company Details
 Table 79. Aquacert Business Overview
 Table 80. Aquacert Legionnaire Disease Testing Product
 Table 81. Aquacert Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 82. Aquacert Recent Development
 Table 83. BioMérieux Company Details
 Table 84. BioMérieux Business Overview
 Table 85. BioMérieux Legionnaire Disease Testing Product
 Table 86. BioMérieux Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 87. BioMérieux Recent Development
 Table 88. Idexx Company Details
 Table 89. Idexx Business Overview
 Table 90. Idexx Legionnaire Disease Testing Product
 Table 91. Idexx Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 92. Idexx Recent Development
 Table 93. Albagaia Company Details
 Table 94. Albagaia Business Overview
 Table 95. Albagaia Legionnaire Disease Testing Product
 Table 96. Albagaia Revenue in Legionnaire Disease Testing Business (2020-2025) & (US$ Million)
 Table 97. Albagaia Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Legionnaire Disease Testing Picture
 Figure 2. Global Legionnaire Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Legionnaire Disease Testing Market Share by Type: 2024 VS 2031
 Figure 4. Urinary Antigen Testing Features
 Figure 5. Direct Fluorescent Antibody (DFA) Stain Features
 Figure 6. Combination Testing (Culture and Urinary Antigen Testing) Features
 Figure 7. Others Features
 Figure 8. Global Legionnaire Disease Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Legionnaire Disease Testing Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Diagnostic Laboratories Case Studies
 Figure 12. Research Centers Case Studies
 Figure 13. Others Case Studies
 Figure 14. Legionnaire Disease Testing Report Years Considered
 Figure 15. Global Legionnaire Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Legionnaire Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Legionnaire Disease Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Legionnaire Disease Testing Market Share by Players in 2024
 Figure 19. Global Top Legionnaire Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Legionnaire Disease Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Legionnaire Disease Testing Revenue in 2024
 Figure 21. North America Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Legionnaire Disease Testing Market Share by Country (2020-2031)
 Figure 23. United States Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Legionnaire Disease Testing Market Share by Country (2020-2031)
 Figure 27. Germany Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Legionnaire Disease Testing Market Share by Region (2020-2031)
 Figure 35. China Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Legionnaire Disease Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Legionnaire Disease Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Legionnaire Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Danaher Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 51. Bio-Rad Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 54. Thermo Fischer Scientific Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 55. BD Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 56. Aquacert Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 57. BioMérieux Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 58. Idexx Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 59. Albagaia Revenue Growth Rate in Legionnaire Disease Testing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools